| |
|
|
|
|
|
|
|||
|
Blood, 1 December 2008, Vol. 112, No. 12, pp. 4555-4564. Prepublished online as a Blood First Edition Paper on September 18, 2008; DOI 10.1182/blood-2008-02-140087.
Submitted February 19, 2008
Division of Rheumatology, Department of Medicine V, University of Heidelberg, Heidelberg, Germany * Corresponding author; email: theresa.tretter{at}med.uni-heidelberg.de.
B cells are well known mediators of humoral immunity and serve as costimulators in the generation of T cell mediated responses. In a number of mouse models though, it was observed that B cells can also downregulate immune reactions, suggesting a dual role for B cells. Due to this discrepancy and so far limited data, we directly tested the effects of primary human B cells on activated CD4+T-helper cells in vitro. We found that under optimal costimulation large, activated CD25+ B cells but not small CD25- B cells induced temporary T cell anergy, determined by cell division arrest and downregulation of cytokine production. In addition large CD25+B cells directly induced CD95-independent apoptosis in a subpopulation of activated T cells. Suppression required direct B-T cell-contact and was not transferable from T to T cell, excluding potential involvement of regulatory T cells. Moreover, inhibitory effects involved an IL-2 dependent mechanism, since decreasing concentrations of IL-2 led to a shift from inhibitory towards costimulatory effects triggered by B cells. We conclude that activated CD25+B cells are able to costimulate or downregulate T cell responses, depending on activation status and environmental conditions which might also influence their pathophysiological impact.
Related Articles in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||